M1A.25
Drug-induced chronic gout, hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Drug-induced chronic gout affecting the hip is a condition where long-term use of certain medications leads to persistent gouty inflammation and joint damage in the hip. Gout is a form of arthritis characterized by the buildup of uric acid crystals in the joints, resulting in pain, swelling, and reduced mobility. When caused by medications, this form of gout develops gradually and can lead to chronic joint problems if not properly managed. Recognizing the symptoms and understanding the causes can help in seeking appropriate medical care and managing the condition effectively.
Causes & Symptoms
Clinical Causes: Prolonged use of medications that increase uric acid levels, such as diuretics (water pills), especially thiazide and loop diuretics. Use of certain immunosuppressive drugs, including cyclosporine and tacrolimus. High doses or long-term use of low-dose aspirin. Medications used in chemotherapy that can interfere with uric acid metabolism. Underlying metabolic conditions that predispose to increased uric acid, exacerbated by medication use.
Key Symptoms: Persistent pain and tenderness in the affected hip joint. Swelling and redness around the joint area. Stiffness, making movement difficult or painful. Warmth and sensitivity in the hip region. Limited range of motion due to joint discomfort. Possible development of tophi (urate crystal deposits) around the hip area over time.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history, physical examination, and laboratory tests. Key steps include: - Reviewing medication history to identify drugs that may elevate uric acid. - Blood tests to measure uric acid levels. - Joint aspiration to obtain fluid from the hip joint for microscopic analysis to identify uric acid crystals. - Imaging studies such as X-rays or ultrasound to assess joint damage and the presence of tophi. - Differentiating drug-induced gout from other types of arthritis or joint conditions.
Treatment Protocols: Managing drug-induced chronic gout generally includes: - Adjusting or discontinuing medications that elevate uric acid levels under medical supervision. - Using medications to lower uric acid levels, such as allopurinol or febuxostat. - Implementing anti-inflammatory treatments during gout flare-ups, including NSAIDs or corticosteroids. - Applying joint rest, ice, and elevation to reduce inflammation. - Addressing lifestyle factors like diet, alcohol consumption, and hydration to manage uric acid levels. - Regular monitoring of uric acid levels to evaluate treatment effectiveness. - In some cases, uric acid-lowering therapy may be lifelong to prevent future attacks and joint damage.
Clinical Advice & FAQs
Billing Guidance
Is M1A.25 a billable ICD-10 code?
Yes, M1A.25 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.25?
Clinical documentation must specify the nature of Drug-induced chronic gout, hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference